Gomez-Bañuelos E - Search Results

1

A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models.

Stabach PR, Sims D, Gomez-Bañuelos E, Zehentmeier S, Dammen-Brower K, Bernhisel A, Kujawski S, Lopez SG, Petri M, Goldman DW, Lester ER, Le Q, Ishaq T, Kim H, Srivastava S, Kumar D, Pereira JP, Yarema KJ, Koumpouras F, Andrade F, Braddock DT. Stabach PR, et al. Among authors: gomez banuelos e. JCI Insight. 2024 Jun 18;9(14):e177003. doi: 10.1172/jci.insight.177003. JCI Insight. 2024. PMID: 38888971 Free PMC article.

2

Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE.

Gómez-Bañuelos E, Goldman DW, Andrade V, Darrah E, Petri M, Andrade F. Gómez-Bañuelos E, et al. Cell Rep Med. 2024 May 21;5(5):101569. doi: 10.1016/j.xcrm.2024.101569. Epub 2024 May 13. Cell Rep Med. 2024. PMID: 38744279 Free PMC article.

3

Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE.

Gómez-Bañuelos E, Goldman DW, Andrade V, Darrah E, Petri M, Andrade F. Gómez-Bañuelos E, et al. medRxiv [Preprint]. 2023 Aug 28:2023.08.28.23294734. doi: 10.1101/2023.08.28.23294734. medRxiv. 2023. Update in: Cell Rep Med. 2024 May 21;5(5):101569. doi: 10.1016/j.xcrm.2024.101569 PMID: 37693590 Free PMC article. Updated. Preprint.

4

Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus.

Gomez-Bañuelos E, Yu Y, Li J, Cashman KS, Paz M, Trejo-Zambrano MI, Bugrovsky R, Wang Y, Chida AS, Sherman-Baust CA, Ferris DP, Goldman DW, Darrah E, Petri M, Sanz I, Andrade F. Gomez-Bañuelos E, et al. Nat Commun. 2023 Mar 20;14(1):1388. doi: 10.1038/s41467-023-37083-x. Nat Commun. 2023. PMID: 36941260 Free PMC article.

5

An update on autoantibodies in systemic lupus erythematosus.

Gómez-Bañuelos E, Fava A, Andrade F. Gómez-Bañuelos E, et al. Curr Opin Rheumatol. 2023 Mar 1;35(2):61-67. doi: 10.1097/BOR.0000000000000922. Epub 2022 Dec 22. Curr Opin Rheumatol. 2023. PMID: 36695053 Free PMC article. Review.

6

Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus.

Gomez-Bañuelos E, Wahadat MJ, Li J, Paz M, Antiochos B, Celia AI, Andrade V, Ferris DP, Goldman DW, Darrah E, Petri M, Andrade F. Gomez-Bañuelos E, et al. JCI Insight. 2022 Oct 10;7(19):e163795. doi: 10.1172/jci.insight.163795. JCI Insight. 2022. PMID: 36040804 Free PMC article.

7

Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis.

Gómez-Bañuelos E, Konig MF, Andrade F. Gómez-Bañuelos E, et al. Curr Opin Struct Biol. 2022 Aug;75:102423. doi: 10.1016/j.sbi.2022.102423. Epub 2022 Jul 11. Curr Opin Struct Biol. 2022. PMID: 35834948 Free PMC article. Review.

8

Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.

Gómez-Bañuelos E, Shi J, Wang H, Danila MI, Bridges SL Jr, Giles JT, Sims GP, Andrade F, Darrah E. Gómez-Bañuelos E, et al. Arthritis Rheumatol. 2022 Nov;74(11):1746-1754. doi: 10.1002/art.42262. Epub 2022 Sep 29. Arthritis Rheumatol. 2022. PMID: 35675168 Free PMC article.

9

Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Trejo-Zambrano MI, Gómez-Bañuelos E, Andrade F. Trejo-Zambrano MI, et al. Among authors: gomez banuelos e. Antioxid Redox Signal. 2022 Mar;36(7-9):389-409. doi: 10.1089/ars.2021.0064. Epub 2021 Jun 4. Antioxid Redox Signal. 2022. PMID: 33906423 Free PMC article. Review.

10

Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study.

Vázquez-Del Mercado M, Martínez-García EA, Daneri-Navarro A, Gómez-Bañuelos E, Martín-Márquez BT, Pizano-Martínez O, Wilson-Manríquez EA, Corona-Sánchez EG, Chavarria-Avila E, Sandoval-García F, Satoh M. Vázquez-Del Mercado M, et al. Among authors: gomez banuelos e. Immunopharmacol Immunotoxicol. 2021 Jun;43(3):328-333. doi: 10.1080/08923973.2021.1910833. Epub 2021 Apr 20. Immunopharmacol Immunotoxicol. 2021. PMID: 33876712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters